Dividend compounder review

PTGX

Protagonist Therapeutics Inc · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score42.00/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 15.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 11.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-130.1M
Free Cash Flow$56.1M
FCF Covers DividendUnknown
Debt / Equity1.49
P/E-
Revenue Growth 5Y10.0%
Net Margin-154.9%
ROE-17.1%
Price vs Trend18.2%
3Y Return297.6%
5Y Return151.7%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

PTGX dividend review warning Warning · Warning

No usable dividend history found.